IL163553A0 - Microorganism for genetic therapeutic treatment ofproliferative diseases - Google Patents
Microorganism for genetic therapeutic treatment ofproliferative diseasesInfo
- Publication number
- IL163553A0 IL163553A0 IL16355303A IL16355303A IL163553A0 IL 163553 A0 IL163553 A0 IL 163553A0 IL 16355303 A IL16355303 A IL 16355303A IL 16355303 A IL16355303 A IL 16355303A IL 163553 A0 IL163553 A0 IL 163553A0
- Authority
- IL
- Israel
- Prior art keywords
- ofproliferative
- microorganism
- diseases
- therapeutic treatment
- genetic therapeutic
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/16—Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.16)
- C12Y301/16001—Spleen exonuclease (3.1.16.1), i.e. 5->3 exoribonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10206325A DE10206325A1 (de) | 2002-02-14 | 2002-02-14 | Ummantelter Mikroorganismus |
| PCT/DE2003/000470 WO2003068954A2 (de) | 2002-02-14 | 2003-02-13 | Mikroorganismus zur gentherapeutischen behandlung proliferativer erkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163553A0 true IL163553A0 (en) | 2005-12-18 |
Family
ID=27674670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16355303A IL163553A0 (en) | 2002-02-14 | 2003-08-13 | Microorganism for genetic therapeutic treatment ofproliferative diseases |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050244374A1 (ko) |
| EP (1) | EP1474519A2 (ko) |
| JP (1) | JP2005517405A (ko) |
| KR (1) | KR20040103941A (ko) |
| CN (1) | CN1646693A (ko) |
| AU (1) | AU2003206663B2 (ko) |
| BR (1) | BRPI0307722A2 (ko) |
| CA (1) | CA2513198A1 (ko) |
| DE (2) | DE10206325A1 (ko) |
| HR (1) | HRP20040832A2 (ko) |
| IL (1) | IL163553A0 (ko) |
| MX (1) | MXPA04007934A (ko) |
| NO (1) | NO20043800L (ko) |
| NZ (1) | NZ535310A (ko) |
| PL (1) | PL372901A1 (ko) |
| RS (1) | RS72404A (ko) |
| RU (1) | RU2004127459A (ko) |
| WO (1) | WO2003068954A2 (ko) |
| ZA (1) | ZA200407358B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008504822A (ja) * | 2004-06-29 | 2008-02-21 | アンチキャンサー インコーポレーテッド | 癌選択的栄養要求株 |
| TWI838389B (zh) | 2018-07-19 | 2024-04-11 | 美商再生元醫藥公司 | 雙特異性抗-BCMAｘ抗-CD3抗體及其用途 |
| US11519007B2 (en) | 2019-02-22 | 2022-12-06 | Arizona Board Of Regents On Behalf Of Arizona State University | Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19720761A1 (de) * | 1997-05-07 | 1998-11-12 | Schering Ag | Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung |
-
2002
- 2002-02-14 DE DE10206325A patent/DE10206325A1/de not_active Ceased
-
2003
- 2003-02-13 BR BRPI0307722A patent/BRPI0307722A2/pt not_active IP Right Cessation
- 2003-02-13 AU AU2003206663A patent/AU2003206663B2/en not_active Ceased
- 2003-02-13 RS YU72404A patent/RS72404A/sr unknown
- 2003-02-13 KR KR10-2004-7012866A patent/KR20040103941A/ko not_active Application Discontinuation
- 2003-02-13 NZ NZ535310A patent/NZ535310A/en unknown
- 2003-02-13 PL PL03372901A patent/PL372901A1/xx not_active Application Discontinuation
- 2003-02-13 WO PCT/DE2003/000470 patent/WO2003068954A2/de active Application Filing
- 2003-02-13 DE DE2003190506 patent/DE10390506D2/de not_active Expired - Lifetime
- 2003-02-13 US US10/504,944 patent/US20050244374A1/en not_active Abandoned
- 2003-02-13 CA CA002513198A patent/CA2513198A1/en not_active Abandoned
- 2003-02-13 EP EP03704314A patent/EP1474519A2/de not_active Withdrawn
- 2003-02-13 JP JP2003568069A patent/JP2005517405A/ja active Pending
- 2003-02-13 RU RU2004127459/13A patent/RU2004127459A/ru unknown
- 2003-02-13 MX MXPA04007934A patent/MXPA04007934A/es not_active Application Discontinuation
- 2003-02-13 CN CNA038082446A patent/CN1646693A/zh active Pending
- 2003-08-13 IL IL16355303A patent/IL163553A0/xx unknown
-
2004
- 2004-09-10 NO NO20043800A patent/NO20043800L/no not_active Application Discontinuation
- 2004-09-14 ZA ZA200407358A patent/ZA200407358B/xx unknown
- 2004-09-14 HR HRP20040832 patent/HRP20040832A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RS72404A (en) | 2006-12-15 |
| AU2003206663B2 (en) | 2007-11-01 |
| KR20040103941A (ko) | 2004-12-09 |
| RU2004127459A (ru) | 2005-05-10 |
| CA2513198A1 (en) | 2003-08-21 |
| BRPI0307722A2 (pt) | 2017-07-04 |
| AU2003206663A1 (en) | 2003-09-04 |
| NO20043800L (no) | 2004-11-08 |
| HRP20040832A2 (en) | 2004-12-31 |
| NZ535310A (en) | 2008-04-30 |
| DE10390506D2 (de) | 2005-01-13 |
| WO2003068954A3 (de) | 2003-10-16 |
| US20050244374A1 (en) | 2005-11-03 |
| AU2003206663B9 (en) | 2003-09-04 |
| ZA200407358B (en) | 2005-11-18 |
| PL372901A1 (en) | 2005-08-08 |
| MXPA04007934A (es) | 2005-11-23 |
| WO2003068954A2 (de) | 2003-08-21 |
| CN1646693A (zh) | 2005-07-27 |
| EP1474519A2 (de) | 2004-11-10 |
| WO2003068954A8 (de) | 2005-10-13 |
| JP2005517405A (ja) | 2005-06-16 |
| DE10206325A1 (de) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
| GB0201850D0 (en) | Therapeutic treatment | |
| GB0216321D0 (en) | Therapeutic treatment | |
| HRP20050163A2 (en) | Combination therapy for hyperproliferative diseases | |
| ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
| GB0316912D0 (en) | Therapeutic treatment | |
| EP1514106A4 (en) | TARGETED THERAPEUTIC PROTEINS | |
| HK1079993A1 (en) | Drugs for treating vascular diseases | |
| GB0320806D0 (en) | Therapeutic treatment | |
| HK1078784A1 (en) | Therapeutic treatment | |
| GB0223367D0 (en) | Therapeutic treatment | |
| AU2003277910A1 (en) | Ocular gene therapy | |
| PL397023A1 (pl) | Środek leczniczy do leczenia AIDS | |
| GB0210464D0 (en) | Therapeutic treatment | |
| GB0329275D0 (en) | Therapeutic treatment | |
| IL163553A0 (en) | Microorganism for genetic therapeutic treatment ofproliferative diseases | |
| GB0307863D0 (en) | Therapeutic treatment | |
| GB0313772D0 (en) | Therapeutic treatment | |
| EP1513550A4 (en) | NEW BACTERIUM FOR THE TREATMENT OF DISEASES | |
| AU2003274649A1 (en) | Diagnostic markers for therapeutic treatment | |
| AU2003260820A8 (en) | Nephritis treatment by gene therapy | |
| AU2003277500A1 (en) | Small electric furnace for medical waste treatment | |
| GB0207138D0 (en) | Novel therapeutic treatment | |
| GB0207139D0 (en) | Novel therapeutic treatment | |
| SI1553950T1 (sl) | Terapevtsko zdravljenje |